NCT02003677 A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Geriatric and Younger Adult Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01999322 A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT01998269 A Mixed Methods Approach to the Development and Testing of the Measure of Drug Self-Management (MeDS) Status COMPLETED Phase N/A
NCT01997021 Effects of Interrupting Sedentary Time on Glycemic Control in Older Overweight and Obese Adults Status COMPLETED Phase NA
NCT01992588 A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01983215 Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin Sites Status UNKNOWN Phase NA
NCT01981031 A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01979471 The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACH Status COMPLETED Phase NA
NCT01978613 Investigation on Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-0987 in an Oral Formulation in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01977859 BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects Status COMPLETED Phase PHASE1
NCT01974778 A Role for Brown Adipose Tissue in Postprandial Thermogenesis? Status TERMINATED Phase NA
NCT01973972 Jump Start Shared Medical Appointments for Diabetes With Weight Management Status COMPLETED Phase NA
NCT01973231 Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01972542 The Usefulness of Postprandial Triglyceride for Assessment of Cardiovascular Risk Status COMPLETED Phase NA